Key result
In ovine fetoplacental artery endothelial cells, Angiotensin II increased eNOS protein expression and NO production (P<0.05) via activation of the MEK1/2/ERK1/2 cascade.
Why the study?
Does Angiotensin II increase eNOS expression and NO production in ovine fetoplacental artery endothelial cells?
Does Angiotensin II increase eNOS expression and NO production in ovine fetoplacental artery endothelial cells?
Angiotensin II stimulates eNOS protein expression and nitric oxide production in ovine fetoplacental artery endothelial cells via the MAPK/ERK cascade, suggesting a role in vasodilation and angiogenesis during pregnancy.
May inform fetoplacental vascular adaptation in pregnancy; leaves open human translation from this ovine model.
Normal pregnancy is associated with high angiotensin II (ANG II) concentrations in the maternal and fetal circulation. These high levels of ANG II may promote production vasodilators such as nitric oxide (NO). ANG II receptors are expressed in ovine fetoplacental artery endothelial (OFPAE) cells and mediate ANG II-stimulated OFPAE cell proliferation. Herein, we tested whether ANG II stimulated NO synthase 3 (NOS3, also known as eNOS) expression and total NO (NO(x)) production via activation of mitogen-activated protein kinase 3/1 (MAPK3/1, also known as ERK1/2) in OFPAE cells. ANG II elevated (P < 0.05) eNOS protein, but not mRNA levels with a maximum effect at 10 nM. ANG II also dose dependently increased (P < 0.05) NO(x) production with a maximal effect at doses of 1-100 nM. Activation of ERK1/2 by ANG II was determined by immunocytochemistry and Western blot analysis. ANG II rapidly induced positive staining for phosphorylated ERK1/2, appearing in cytosol after 1-5 min of ANG II treatment, accumulating in nuclei after 10 min, and disappearing at 15 min. ANG II increased (P < 0.05) phosphorylated ERK1/2 protein levels. Activation of ERK1/2 was confirmed by an immunocomplex kinase assay using ELK1 as a substrate. PD98059 significantly inhibited ANG II-induced ERK1/2 activation, and the ANG II-elevated eNOS protein levels but only partially reduced ANG II-increased NO(x) production. Thus, in OFPAE cells, the ANG II increased NO(x) production is associated with elevated eNOS protein expression, which is mediated at least in part via activation of the mitogen-activated protein kinase kinase1 and kinase2 (MAP2K1 and MAP2K2, known also as MEK1/2)/ERK1/2 cascade. Together with our previous observation that ANG II stimulates OFPAE cell proliferation, these data suggest that ANG II is a key regulator for both vasodilation and angiogenesis in the ovine fetoplacenta.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2005) studied Ovine fetoplacental artery endothelial cells. Angiotensin II was evaluated on eNOS protein expression and total NO(x) production (p=<0.05). In ovine fetoplacental artery endothelial cells, Angiotensin II increased eNOS protein expression and NO production (P<0.05) via activation of the MEK1/2/ERK1/2 cascade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: